Search results
BioNTech Cancer Drug Licensed From MediLink Faces FDA Delay
Bloomberg· 7 days agoThe Food and Drug Administration delayed a breast- and lung-cancer trial of an experimental...
AstraZeneca’s lung cancer drug approved by US FDA for combination chemotherapy treatment | Invezz
Invezz· 7 days agoAstraZeneca, the largest pharmaceutical group in Britain, announced that the U.S. Food and Drug...
US FDA puts partial clinical hold on BioNTech's early-stage study of cancer drug
Reuters· 7 days ago, opens new tab on Monday the U.S. Food and Drug Administration has placed a partial clinical hold...
Lung Cancer Drug Elicits Unprecedented Results in New Trial
GoodNewsNetwork· 5 days agoWith lung cancer being the leading cause of cancer-related deaths worldwide, news of the unprecedented success of a new</ ...
Johnson & Johnson submits BLA to FDA for lung cancer drug
Pharmaceutical Technology via Yahoo Finance· 6 days agoJohnson & Johnson has filed a biologics licence application (BLA) with the US Food and Drug...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 4 days agoAnd, last month, Pfizer unveiled positive results from a lung cancer study. The company tested its ...
Sylvester Cancer Tip Sheet - June 2024 | Newswise
Newswise· 3 days agoA hematologist endorses FDA approval of a new cancer drug, research shows new use for an older drug, multiple myeloma research may secure FDA approval of a
Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
Benzinga via Yahoo Finance· 6 days agoCombining Immunotherapy And Chemotherapy Is Emerging As A New Standard In Ca
Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short
BioPharma Dive via Yahoo Finance· 6 days agoBelharra will use its chemoproteomics technology to identify immune drugs for Sanofi. Elsewhere,...
Rethinking Clinical Trial Design and Cure in NSCLC
Medscape· 4 days agoMark Kris discusses clinical trial design and the goal of cure in non–small cell lung cancer.